JMVIX
Price
$16.44
Change
+$0.07 (+0.43%)
Updated
Jul 3 closing price
Net Assets
1.94B
MVCAX
Price
$31.58
Change
+$0.12 (+0.38%)
Updated
Jul 3 closing price
Net Assets
17.33B
Interact to see
Advertisement

JMVIX vs MVCAX

Header iconJMVIX vs MVCAX Comparison
Open Charts JMVIX vs MVCAXBanner chart's image
Janus Henderson Mid Cap Value S
Price$16.44
Change+$0.07 (+0.43%)
VolumeN/A
Net Assets1.94B
MFS Mid Cap Value A
Price$31.58
Change+$0.12 (+0.38%)
VolumeN/A
Net Assets17.33B
JMVIX vs MVCAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JMVIX vs. MVCAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JMVIX is a Buy and MVCAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 17.3B vs. JMVIX (1.94B). MVCAX pays higher dividends than JMVIX: MVCAX (0.87) vs JMVIX (0.36). JMVIX was incepted earlier than MVCAX: JMVIX (16 years) vs MVCAX (24 years). JMVIX (1.14) is less costly to investors than MVCAX (1.00). JMVIX is a more actively managed with annual turnover of: 37.00 vs. MVCAX (27.00). MVCAX has a lower initial minimum investment than JMVIX: MVCAX (1000) vs JMVIX (2500). JMVIX annual gain was more profitable for investors over the last year : 1.52 vs. MVCAX (1.09). MVCAX return over 5 years is better than : 60.39 vs. JMVIX (27.27).
JMVIXMVCAXJMVIX / MVCAX
Total Expense Ratio1.140.99115%
Annual Report Gross Expense Ratio1.141.00114%
Fund Existence16 years24 years-
Gain YTD3.2662.934111%
Front LoadN/A6%-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets1.94B17.3B11%
Annual Yield % from dividends0.360.8742%
Returns for 1 year1.521.09139%
Returns for 3 years10.6518.7057%
Returns for 5 years27.2760.3945%
Returns for 10 years-12.5664.61-19%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WMGRX24.310.35
+1.46%
Macquarie Mid Cap Growth R
MASPX30.380.28
+0.93%
BlackRock Advantage SMID Cap Instl
MLPSX90.300.45
+0.50%
ProFunds Mid Cap Value Svc
NQGAX39.550.16
+0.41%
Nuveen Global Equity Income A
PHLAX32.400.06
+0.19%
PGIM Jennison Health Sciences A